Statement from UniTao Pharmaceuticals, LLC March 20, 2015

Statement from UniTao Pharmaceuticals, LLC
March 20, 2015

Today, UniTao Pharmaceuticals, LLC (UniTao) announced plans to idle its pharmaceutical operations in Petersburg, Virginia, until business conditions improve. UniTao is expected to keep a small team on-site to ensure the facility remains a viable pharmaceutical operation in the near future. The impacted employees will receive a severance package for their brief service to the company.  UniTao has informed the Governor's office and the City of Petersburg that it will not be accepting the economic development grants offered by the state and the locality since the company cannot meet the obligations of those agreements at this time. 

Suggested Articles

The FDA asked five drugmakers to pull their version of extended-release metformin off U.S. shelves after finding carcinogen contamination.

The FDA backtracked on its earlier testing and found NDMA contamination in the extended release formulation of certain generic versions of metformin.

GSK has formed several collaborations across the globe that will use its AS03 adjuvant to develop vaccines against the novel coronavirus.